The clinical performance is complex and often involves multiple systemic stresses. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in linking domestic and foreign experts and teams to provide accurate diagnosis and treatment plans. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat neurological disorders have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions, with timely adjustments according to changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of neurological impairment associated with PML. The platform serves a team of authoritative experts at home and abroad in the field of neural systems coupled with China's international medical services, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.